New device eases a tricky task in defibrillator surgery

July 15, 2012 By James Walsh in Cardiology

Dr. Pierce Vatterott and his team of nurses and technicians worked smoothly and efficiently in the chilly catheter lab at St. Paul's United Hospital. It was complex and potentially risky work, removing four leads - wires that connect a defibrillator to the heart - from an 84-year-old man.

But Vatterott and his team are experienced hands and they had a new tool, to boot, a laser sheath that more quickly and easily cuts through to free the wires.

Millions of people need defibrillators and to keep them alive. The wires that lead to those devices sometimes need to be replaced because of age or defect. But one wrong move when extracting a lead can leave a piece of the wire behind or, worse, perforate the heart or blood vessel. So anything that makes lead extraction safer is a good thing, Vatterott said.

"It has helped," he said of the GlideLight, made by Colorado Springs, Colo.-based Spectranetics and recently approved by the U.S. . "It has definitely helped."

Potentially dangerous problems in the past five years with leads made by Inc. and, most recently, St. Jude Medical Inc., have left tens of thousands of people facing difficult choices. Do they thread new leads through the same vein to the heart, but leave the old ones - disconnected - in place? Or do they pull them out entirely?

Sometimes, the congestion of too many wires in the vein can block blood flow. One lead rubbing against another also can cause inappropriate shocking. If a lead becomes infected, it has to come out.

"The extraction of leads that have been implanted in patients for years is one of the most complex procedures cardiologists perform," said Dr. Robert Hauser, a senior consulting cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital. "It should be done only by highly experienced physicians and their teams in hospitals equipped for ."

Vatterott and his team at United Heart and Vascular Clinic at United Hospital fit the bill. They have done about 2,000 lead extractions over the years and were the first to use the new GlideLight device in Minnesota. The doctor said they are doing one to two lead extractions each week. GlideLight is also being used at Abbott Northwestern.

"There are studies out there that show the more (extractions) you do, the less complications you have," Vatterott said. "So much depends on the experience of the doctor and the team. And it's really the team. Every person in that room has saved me or saved the patient at some point."

Kurt Riebe, 84, and his wife, Lorraine, will celebrate 63 years of marriage in August. Lorraine calls it "a nice start."

The North St. Paul, Minn., couple has every intention of celebrating many anniversaries to come. So when they learned that Riebe had an infection around his defibrillator-pacemaker, the decision was made to take out the device and the four leads that had been implanted and replace them. It would not be easy, Vatterott said. Riebe is frail.

But on Monday of last week, the GlideLight made it easier.

Not that a five-hour procedure, with Vatterott and his nurses monitoring blood pressure, watching multiple monitors, cutting out infected tissue, cauterizing and snaking wires and something that looks like a laser-tipped black soda straw into the heart can be called easy.

It took two hours just to do the prep work to get the leads ready for removal. As he worked, Vatterott praised his team time and again, pointing out that each has 15 to 20 years of experience. First, they worked to clear the "pocket" where the defibrillator was located. Then they disconnected the wires from the device, temporarily hooking up Riebe to an external pacemaker.

Then, the doctor slid the GlideLight over the first lead, snaking it down the vein into Riebe's heart. Along the way, the device made a clicking sound as the laser cut through the scar tissue that blocked its path.

Once clear, the doctor slowly pulled out the lead before removing the sheath.

Then, it was on to the second lead. Then the third. Then the fourth. During the entire procedure, a surgical team was standing by to assist if a complication arose. One never did.

By the end of the week, Riebe was home and doing well.

(c)2012 Star Tribune (Minneapolis)
Distributed by MCT Information Services

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 38 minutes ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 3 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 3 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 3 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created 19 hours ago | popularity 5 / 5 (1) | comments 0


Scientists uncover molecular roots of cocaine addiction in the brain

Researchers at Johns Hopkins have unraveled the molecular foundations of cocaine's effects on the brain, and identified a compound that blocks cravings for the drug in cocaine-addicted mice. The compound, already proven safe ...

Taming suspect gene reverses schizophrenia-like abnormalities in mice

Scientists have reversed behavioral and brain abnormalities in adult mice that resemble some features of schizophrenia by restoring normal expression to a suspect gene that is over-expressed in humans with ...

Acne treatment: Natural substance-based formula is more effective than artificial compounds

University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance ...

Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine

The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...

A molecular explanation for age-related fertility decline in women

(Medical Xpress)—Scientists supported by the National Institutes of Health have a new theory as to why a woman's fertility declines after her mid-30s. They also suggest an approach that might help slow ...

Addiction to unhealthy foods could help explain the global obesity epidemic

Research presented today shows that high-fructose corn syrup can cause behavioural reactions in rats similar to those produced by drugs of abuse such as cocaine. These results, presented by addiction expert Francesco Leri, ...